David Vaillencourt, CEO of GMP Collective, discusses the critical role of Good Manufacturing Practices (GMP) in the cannabis industry. David and host [Brasco's Name] delve into the impact of GMP standards on consumer safety, international trade, and building a sustainable cannabis market. They explore the implications of the Cannabis Standards and Regulations Act (CSRA), a Senate bill pushing for ASTM standards and FDA oversight of cannabinoid manufacturers.
This conversation addresses the challenges of inconsistent lab testing results and how GMP certification can improve accuracy and reliability. David provides valuable insights on preventing product recalls by establishing a framework for quality control and risk mitigation. Furthermore, he examines the importance of GMP compliance for competing in the global cannabis landscape and provides practical advice for cannabis businesses on integrating quality management systems and best practices.